Breaking News
Investing Pro 0
Cyber Monday SALE: Up to 54% OFF InvestingPro+ CLAIM OFFER

Breaking News

Chinese stocks rally on hints of authorities' commitment to reopening

USANA (USNA) to Report Q2 Earnings: What's in the Cards?

By Zacks Investment ResearchStock MarketsJul 17, 2020 03:16AM ET
www.investing.com/analysis/usana-usna-to-report-q2-earnings-whats-in-the-cards-200531077
USANA (USNA) to Report Q2 Earnings: What's in the Cards?
By Zacks Investment Research   |  Jul 17, 2020 03:16AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
IONS
-2.96%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
USNA
+0.77%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
UTHR
+0.98%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
TBPH
-1.04%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

USANA Health (NYSE:USNA) Sciences Inc. USNA is scheduled to report second-quarter 2020 results on Jul 21, aftermarketclose.

The company flaunts a mixedearningssurprise history, having surpassed expectations in three of the trailing four quarters by 63.14%, on average. In the last reported quarter, the company delivered an earnings surprise of 115.79%.

Shares of USANA have gained 12.9% in the year so far against the industry’s decline of 5.6%.


Let's see how things are shaping up for this announcement.

Factors to Consider

USANA develops and manufactures high-quality nutritional supplements, healthy foods and personal care products that are sold directly to associates and preferred customers throughout the United States, Canada, and many more countries.

USANA expects the COVID-19 pandemic to affect the operational results for the entire year. The results were also affected by the same in the first quarter and the trend most likely prevailed in the second quarter.

For the second quarter, the company had projected sales in the range of $250 million. The ongoing pandemic has most likely impacted both sales and earnings in the second quarter.

In July 2020, USANA received another seal of approval from third-party tester, ConsumerLab.com, for its flagship supplement, USANA CellSentials. This is the highly regardedseal of approval from the ConsumerLab.com. USANA CellSentials is unlike any other nutritional supplement inthe market because of its unique ability to activate the cells' innate natural responses to protect and renew themselves. The seal is likely to have ledto increased sales for the company in the second quarter.

In the same month, USANA’s CopaPrime+ study, which was conducted in collaboration with Deakin University in Australia and Nanyang Technological University in Singapore, showed that the study supports three cognitive measures—working memory and accuracy, attention speed and response time, and brain efficiency—only 45 minutes after participants took a single dose.

The CopaPrime+ study showed that participants who took the supplement had significant differences in working memory and accuracy, speed of attention and response time, and brain efficiency over those who were given placebo. With these results, the company reiterated its decision to formulate CopaPrime+ with three nootropics — American ginseng, bacopa monnieri, and coffee-fruit extract. We expect an update on this in the second quarter.

What Our Model Indicates

Our proven model does not conclusively predict an earnings beat for USANA this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that is not the case here as you will see below.

Earnings ESP: USANA has an Earnings ESP of 0.0%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Zacks Rank: The company carries a Zacks Rank #1.

Stocks to Consider

Here are some biotech stocks with the right mix of elements to beat on earnings this time around:

Theravance Biopharma (NASDAQ:TBPH) Inc. TBPH has an Earnings ESP of +20.95% and a Zacks Rank #3.

United Therapeutics (NASDAQ:UTHR) Corp. UTHR has an Earnings ESP of +9.13% and a Zacks Rank of 3.

Ionis Pharmaceuticals (NASDAQ:IONS), Inc. IONS has an Earnings ESP of +30.77% and aZacks Rank of 3.

These Stocks Are Poised to Soar Past the Pandemic

The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.

Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.

See the 5 high-tech stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

United Therapeutics Corporation (UTHR): Free Stock Analysis Report

USANA Health Sciences, Inc. (USNA): Free Stock Analysis Report

Theravance Biopharma, Inc. (TBPH): Free Stock Analysis Report

Ionis Pharmaceuticals, Inc. (IONS): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research
USANA (USNA) to Report Q2 Earnings: What's in the Cards?
 

Related Articles

USANA (USNA) to Report Q2 Earnings: What's in the Cards?

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (1)
Andrew Ng Kum Seng
Andrew Ng Kum Seng Aug 14, 2022 9:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
How can buy USNA trading signal to succees TP?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email